Abstract
Purpose of Review
To provide references for further research and for the application of the genus Patrinia, recent studies concerning the phytochemistry and pharmacology of the genus Patrinia were summarized.
Recent Findings
There are about 20 species of Patrinia genus around the world which is mainly distributed throughout East Asia and North America, and about 10 species, 3 subspecies, and 2 variant species in China which have been used as traditional Chinese medicine in controlling fever and inflammation along with detoxication, mobilization of blood circulation, and treatment for stasis, among others. The tender leaves of some species could be used for food. The main chemical constituents are triterpenoids, iridoids, flavonoids, anthraquinone, coumarin, lignans, steroids organic acids, and alkaloids in Patrinia. Pharmacology researches showed that Patrinia possesses sedative, antibacterial, antivirus, anti-tumor activities, and protective effects of liver and gallbladder. It can be used in the treatment of neurasthenia, hepatitis, and pneumonia.
Summary
The plant resources of genus Patrinia are rich; at the same time, the genus has complex chemical constituents and abundant pharmacological activities.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
There are about 20 species of genus Patrinia all over the world which are mainly distributed in East Asia and North America. Therein, about 10 species, 3 subspecies, and 2 variant species are native to China. According to the Chinese traditional pharmaceutical books, 9 species and 2 subspecies have been used as medicinal herbs in China [1], which are widely distributed in the entire country. The Patrinia species in China include Patrinia scabiosaefolia Fisch. ex Trevir.; Patrinia sibirica (Linn.) Juss.; Patrinia glabrifolia Yamamoto et Sasaki; Patrinia speciosa Hand. Mazz; Patrinia intermedia (Horn.) Roem. et Sehult; Patrinia rupestris (Pall.) Juss.; subsp. rupestris; subsp. scabra (Bunge) H. J. Wang; Patrinia heterophylla Bunge; subsp. heterophylla; subsp. angustifolia (Hemsl.) H. J. Wang; Patrinia villosa (Thunb.) Juss.; subsp. punctifolia H. J. Wang; Patrinia punctiflora Hsu et H. J. Wang; var. punctiflora; var. robusta Hsu et H. J. Wang; monandra C.B.Clarke; var. monandra; and var. formosana (Kitam.) H. J. Wang.
The main chemical constituents of genus Patrinia are triterpenoids, followed by iridoids, flavonoids, anthraquinones, coumarins, lignans, organic acids, and alkaloids. Moreover, the difference among Patrinia plants, about their species and skeleton of terpenoids, flavonoids, and glycosides, can be used as the basis of chemical taxonomy among species [2].
In China, there is a long application story of the genus Patrinia. P. scabiosaefolia and P. villosa are colloquially named “Bai Jiang Cao” recorded in the “Sheng Nong’s Herbal Classic”, and they were ranked as “Middle grade” herbs. According to the “Compendium of Materia Medica”, Bai Jiang Cao is often used to treat gynecopathy. Many species of this genus, for example, P. scabiosaefolia, P. villosa, and P. heterophylla have been used as folk medicine with the effects of anti-inflammation, detoxification, antibacterial, sedation, and antispasmodic in China [3]. Besides, the young leaves and/or flower buds of some Patrinia species such as P. scabiosaefolia, P. villosa, P. punctiflora, and P. glabrifolia are also used as vegetables in some areas of China.
The important research value of genus Patrinia is its significant clinical effect in the treatment of neurasthenia and postpartum diseases. However, only a few species of this genus were studied, including P. scabiosaefolia, P. villosa, and P. scabra, which were focused on the chemical components, less published reports concerning their pharmacology, and no comprehensive research combining the components and pharmacology together [4]. In this paper, we comprehensively summarized the chemical constituents (Table 1) and pharmacological activities of Patrinia.
Chemical Constituents
Triterpenoids
Eighty-two compounds (Compounds 1–82 in Figs. 1,2,3) have been obtained from 5 species of Patrinia. Based on the skeleton of sapogenin, saponins can be divided into three types: oleanane, hederagenin, and ursane. The main glycosyls are xylose, rhamnose, arabinose, and glucose.
Iridoids
Studies on iridoids in Patrinia were reported as early as the 1970s. Villoside and loganin (Compounds 91–92 in Fig. 4) were isolated from P. villosa by Heihachiro Taguchi [37]. Furthermore, the C1–OH of iridoid compounds was easily combined with sugar as glycosides; C7 and C8 are sometimes substituted by hydroxyl groups and combined with sugar as glycosides. In addition, C4 is often attached by carbonyl group derivatives. Until now, there were 71 iridoids isolated from Patrinia (Compounds 83–153 in Fig. 4) with the main skeletons such as iridoids and secoiridoids.
Flavonoids
There were 32 flavonoid compounds (Compounds 154–186 in Fig. 5) isolated from P. rupestris, P. villosa, P. heterophylla, P. scabra, and P. scabiosaefaolia. Their skeletons were mainly composed of flavonoids, flavonols, dihydroflavonoids, and their glycosides as well as a small amount of chalcones. The main glycosyls were rhamnose and glucose.
Anthraquinones
Liu et al. [47] isolated compounds 187–192 from P. scabra in 2010 (Fig. 6). The main glycosyls are rhamnose and glucose.
Phenylpropanoid Derivatives
Coumarins
There are few reports which have been published concerning coumarins (Compounds 193–197 in Fig. 7).
Lignans
Lignans usually existed in the form of glycosides. Twenty-two lignans and their glycosides (Compounds 198–219 in Fig. 8) have been identified from the genus Patrinia. Up to now, most lignans from Patrinia are mainly concentrated in P. scabra, while a few in P. villosa and P. scabiosaefaolia.
Phenylpropionic Acids
To date, five coumarins (Compounds 220–224 in Fig. 9) were isolated and identified from the roots and rhizomes of the genus Patrinia.
Steroids
Eight steroids (Compounds 225–232 in Fig. 10) have been isolated from the whole plants of the genus Patrinia. Therein, compounds 225–229 were isolated from P. scabiosaefaolia, compounds 230–231 from P. rupestris and compound 232 from P. villosa.
Essential Oils
Based on the supercritical CO2 extraction and GC-MS, Yang et al. extracted and identified 41 chemical components from P. scabiosaefaolia, mainly including monoterpenes, sesquiterpenes and the corresponding oxygen-containing derivatives, and caryophyllene is the highest (25%) among them [72]. Tian et al. identified 9 compounds from P. scabiosaefaolia and 6 compounds from P. heterophylla [73]. Ma et al. analyzed extracts of P. villosa by GC-MS and identified 9 compounds [74]. He et al. studied the essential oils from the roots and rhizomes of P. scabra by capillary GC and GC-MS-computer system and identified 26 compounds, of which the main compounds are β-caryophyllene and α-humulene [75].
Other Compounds
Li et al. [26] isolated protocatechuic acid and Di [43] isolated 2,3-dihydroxypropyl-9Z,12Z-octadecadienote from P. scabra.
PHB-P1 and PHB-P2 are two different polysaccharide compounds in P. heterophylla, and these species also contained ketose, uronic acids and others. The content of uronic acids is in the range of 18–21% [76].
Biological Activities
Sedative and Analgesic Activities
Studies have shown that the essential oils distilled from P. scabra have sedative effect and suggested that patrinene and isopatrinene might be the representative active sedative and hypnotic components in Patrinia species, which can directly act on the central nervous system to perform an analgesic effect. However, the effects vary in different species.
The ethanol extracts of P. scabiosaefaolia have effective sedative effect on mice, with longer sedative time, but no hypnotic effect. The essential oils of P. scabiosaefaolia also have sedative effect, but duration is shorter [56]. All 20% tincture, tablets of 60% ethanol extract and essential oil sealed capsules of P. scabiosaefaolia have a certain therapeutic effect on the treatment of neurasthenia and neurasthenia syndrome with insomnia as the main symptom, and the latter has a significant improvement over the former two. In addition, pharmacological studies also showed that the essential oil sealed capsule had little or no toxicity [77]. Xiao et al. observed the extracts of P. scabiosaefaolia by n-butanol, ethyl acetate, and petroleum ether had a synergistic central nervous inhibitory effect with pentobarbital sodium, and the sedative effect of the n-butanol extract was the strongest [78].
The essential oils distilled from P. scabra can significantly prolong the sleeping time of mice caused by intraperitoneal injection of pentobarbital sodium, with no detectable cytotoxicity, which is similar to the essential oils from P. heterophylla, but the intensity of action is weaker than that of P. scabiosaefaolia [79]. In addition, the essential oil distilled from P. scabra has the activities of inhibiting the spontaneous activity of mice induced by pentobarbital sodium and activating the P-450 [80].
The water extract of P. villosa also has obvious central nervous inhibitory effect and the essential oils had a synergistic central nervous inhibitory effect with pentobarbital sodium [81].
Antibacterial and Antiviral Activities
Cai et al. reported that the extracts of P. scabiosaefolia oral liquid, granules and P. villosa granules had significant antibacterial properties against Staphylococcus aureus, while they had different degrees of inhibitory effects on Staphylococcus albus, typhoid bacillus, Streptococcus B, pneumococcus, Escherichia coli, dysentery bacillus, and Pseudomonas aeruginosa [82]. The essential oils distilled from P. scabiosaefolia have a strong inhibitory effect on Staphylococcus aureus and Streptococcus, but they have weak bacteriostatic effect against Pasteurella and Salmonella, while the ethanol extract has weak bacteriostatic effect on all the above bacteria [83].
By improving microcirculation and cellular immune function, some species like P. villosa can promote the absorption of local blood stasis, treat chronic pelvic inflammation, and achieve the functions of antibacterial and anti-inflammatory [84]. The aqueous extract of P. scabiosaefolia was effective for the acute pancreatitis induced by cholecystokinin octa peptide in rats [85]. The total saponins from P. villosa could inhibit the swelling ears of mouse induced by xylene and the increase of peritoneal capillary permeability induced by acetic acid in mice to varying degrees, which indicated that saponins were the effective anti-inflammatory components of P. villosa [86].
The compound derived from Patrinia herbs has obvious therapeutic effect on chronic pelvic inflammatory disease in rats caused by mixed bacterial solution, and its mechanism may be to restore immune function to the normal range [87].
There are two polysaccharides, AP3 and AP4 isolated from Patrinia herbs, which was proved to possess significant antivirus activity. AP3 showed significant dose-dependent antiviral effects against respiratory syncytial virus (RSV) in Hela cell culture, and its median cytotoxic concentration (TC50), median effective dose (EC50), and therapeutic index (TI) were 11.45 mg/mL, 0.0986 mg/mL, and 116.12, respectively [88]. AP4 could significantly inhibit the proliferation of RSV in vitro and TC50, EC50, and TI were 10.89 mg/mL, 0.0801 mg/mL, and 135.95, respectively. It also has a significant inhibitory effect on influenza virus in chicken embryos [89]. Triterpenoid compound (Sulfa patrinosides) isolated from the seeds of P. villosahas demonstrated the effect of inhibiting HIV [90]. In addition, the methanol extracts of P. villosa showed marked antiviral activity against influenza virus A/Puerto Rico/8/34 (H1N1) by a viral replication inhibition test [91].
Antitumor Activity
The ethanol extract of P. heterophylla could inhibit the proliferation of PC-3 cells in a concentration- and time-dependent manner. Moreover, further study also demonstrated that i.p. administration of 20, 40, and 60 mg/kg ethanol extracts exhibited a significant inhibitory effect on the growth of transplantation tumor, with inhibition rate of 23.9%, 48.4%, and 53.6% on S180 cells and 21.0%, 46.3%, and 57.2% on H22 cells, respectively [92]. Xu et al. screened the antitumor parts of P. heterophylla and found that the chloroform extract had the strongest antitumor activity [93], and P. heterophylla glucosides tablets had a strong inhibitory effect on Ehrlich Ascites carcinoma and S180 sarcoma. Later, he further found that the tablets also had a good inhibitory effect on human colorectal cancer cells [94]. In vitro, PHB-P1 can inhibit the proliferation of HeLa cells and reduce the activity of gelatinase and telomerase, thereby inducing apoptosis of HeLa cells. In addition, PHB-P1 can also induce the apoptosis of tumor cells in U14 tumor-bearing mice and block tumor cells in G0/G1 phase [76]. The iridoid aglycones PS-1 and villosol of P. scabra can significantly inhibit the growth of C26 cell line in a dose-dependent manner, and PS-1 can also inhibit the growth of DU-145 and PC-3 cells [95, 96]. By comparing the difference among P. scabra extracts on growth-inhibiting effects of tumor cell in vitro, Chen et al. found that the total lignans and total saponins of P. scabra inhibited the tumor cells SPCA-1, HepG2 and K562 in vitro, among which the P. scabra lignanoid inhibited the growth of K562 cells most significantly through promoting the apoptosis of K562 cells. The P. scabra lignanoid has obvious inhibitory effect on the growth of human chronic myeloid leukemia cells [97, 98]. Some other studies found that the iridoid aglycones of P. scabra can significantly improve the thymus index and spleen index of mice, promote the proliferation of spleen lymphocytes induced by Con-A, improve the level of serum hemolysin in mice, increase the activity of NK cells, and enhance the phagocytic activity of peritoneal macrophages. It was found that iridoid aglycones could significantly improve the immune function of mice, which might be the potential mechanisms of P. scabra in inhibiting tumor growth [99].
The water extract of P. villosa inhibited the growth and proliferation of U14 cervical cancer cells, reduced the serum MDA level of U14 tumor-bearing mice, and increased the activity of T-AOC and SOD [100]. The saponin extracted from P. villosa (SPVJ) (50 mg/kg and 100 mg/kg) effectively reduced the weight of U14 cervical tumor (35.1% and 57.1%, respectively). Compared with the control group, SPVJ (100 mg/kg) significantly increased the number of tumor cells and cells in apoptosis in the G0/G1 phase, decreased the number of cells in S phase and G2/M, inhibited the proliferating cell nuclear antigen (PCNA) of the tumor cell and downregulated the expression of mutant p53 and Bcl-2 protein [89].
The extracts from the roots of P. scabiosaefolia had an inhibitory effect on S180 [101]. It was observed by MTT assay that the saponins from P. scabiosaefolia could prolong the survival of mice with Ehrlich ascites carcinoma, which showed the antitumor effect in vivo of the saponins from P. scabiosaefolia. But the effect intensity is relatively weak [102]. The ethanol extract of P. scabiosaefolia (EEPS) could inhibit colorectal cancer (CRC) growth both in vivo and in vitro, without apparent adverse side effects. Besides, EEPS could inhibit the expression of anti-apoptotic Bcl-2, enhance pro-apoptotic Bax expression and induce the loss of mitochondrial membrane potential and activation of caspases-9 and -3 in HT-29 cells [103]. Liu et al. also found EEPS could inhibit the phosphorylation of STAT3 in U266 cells and the expression of cyclin D1 and Bcl-2 [104]. In addition, EEPS treatment not only significantly blocked G1 to S phase cell cycle progression, but also decreased the expression of pro-proliferative CyclinD1 and CDK4, at both the mRNA and protein levels [105•].
Hepatoprotective Activity
Patrinia herbs promoted the regeneration of liver cells and inhibits cell degeneration [106]. For example, the extract from P. villosa inhibited liver lipid peroxidation in rats in vitro with a dose–effect relationship [107], and the fruit branch extract of P. villosa possessed marked hepatoprotective activity [106]. The oleanolic acid from Patrinia plants is a common component of anti-hepatitis activity, which has a significant protective effect on liver injury and reduction of serum alanine amino transferase and triglyceride accumulation in the liver [108].
Effect on the Immune System
The anti-tumor mechanism of the genus Patrinia is not only related to the direct cytotoxic effect, but also to the regulation of the immune system. Bai Jiang Cao has an anti-endotoxin effect, through a direct destruction of endotoxin, rather than a temporary inhibition of endotoxin activity. Many evidence showed that Bai Jiang Cao could markedly inhibit the secretory granulocyte of Kupffer’s cells induced by lipopolysaccharide (LPS), i.e., the colony-stimulating factor of the macrophage (CM-CSF) increased the content of prostaglandin E2 secreted by Kupffer’s cells [109, 110]. The ethanol extract of P. scabra could increase the phagocytosis activity and cytotoxic effect of macrophages as well as the percentage of lymphocyte ANAE positive lymphocytes and EA rosette formation in mice, and inhibit the growth of S180 in mice, which might be related to the enhancement of nonspecific immune function [111]. Wang et al. demonstrated that the water extracts from P. scabra could prolong the life expectancy of mice, improve erythrocyte immunologic function and increase the CD35 and CD44s contents of the red blood cell [112]. Wang et al. reported that the P. scabra extracts separated by macroporous adsorptive resins at dosages ranging from 0.5 to 2.0 g/kg improved the spleen and thymus indexes of S180 tumor-bearing mice, strengthened the transformation functions of spleen T and B lymphocytes and prompted the killing abilities of NK and LAK cells. Moreover, the antibodies producing ability of the B cells in vivo were strengthened, and the amount ratio of CD4+ cells to CD8+ cells was increased [113].
Effect on the Blood System
Sun et al. reported that P. heterophylla demonstrated a significant inhibitory effect on acute leukemia cells [114]. The reason might be related to the hederagenin from P. heterophylla, which could inhibit the proliferation of HL-60 cells at low concentrations (10 ~ 40 μmol/L) and cause cell death at high concentrations (40 ~ 50 μmol/L). The main mechanism to achieve the above effects was the G1 phase inhibition and apoptosis induction of HL-60 cells caused by hederagenin [115].
Zhang et al. conducted subacute experiments in dogs with P. scabra. Results showed that P. scabra could increase the number of white blood cells, temporarily decrease the number of platelets, and produce granular lesions in liver cells [116]. Another research found that the ethanol extract of P. scabra (i.p.) showed the hemostasis effect in blood vessels of rabbits, which might be related to the significant promotion on the aggregation of circulating platelets [117].
The extracts of P. heterophylla at the doses of 750 mg/kg and 375 mg/kg could reduce the blood viscosity of U14 cervical cancer mouse in different shear rates and improve the indexes of hemorheology [118]. Using cell culture technology, it was found that the water extract of P. heterophylla has a “two-way” regulatory effect, which means it was not only a strong anticancer drug, but also an accelerator of hematopoietic progenitor cells. When the dose is high, it will demonstrate the effect of killing tumor cells, whereas it will induce the formation of stromal cells and promote hematopoiesis by secreting the hematopoietic-stimulating factor at a low dose [119].
Effect on Gastrointestinal Tract Function
It was proved that Bai Jiang Cao could eliminate local inflammation, improve microcirculation of lesions, and effectively treat chronic ulcerative colitis [120]. Besides, the animal test about the tannin extract of P. villosain vitro showed strong effect (P < 0.05) on small intestinal peristalsis of mice and significantly reduced the times of defecation, indicating that the tannin extract would have a two-way therapeutic effect on constipation and diarrhea [121].
Other Activities
Bai Jiang Cao also can be used to treat gonorrhea and infantile diarrhea [2], while its extracts have significant antioxidant activity in vivo, and decrease malondialdehyde (MDA) content in serum and tissues [122]. P. scabiosaefolia possesses the effect of inhibiting the DNA polymerase of hepatitis B virus. P. villosa has a significant anti-hypoxia effect [123]. It is also used to treat fallopian tube obstruction and semen in liquefaction as well as poisonous snakebite [124, 125]. In addition, its methanol extracts have inhibitory activity against substance P (SP)-induced itching [126].
Future Perspectives and Conclusion
Patrinia plants have a long history of medicinal application in China. According to the Chinese Pharmacopeia of 1977, the whole herb including the roots of P. scabiosaefolia and P. villosa were authentic Bai Jiang Cao with high development and utilization value. As a traditional Chinese medicine, this genus has the advantages of abundant bioactive ingredients, wide application, rich resources, and others. It has long been used in China for the treatment of neurasthenia, postpartum disease, lung carbuncle, dysentery, and leucorrhea. Based on the studies both in vitro and in vivo, the genus Patrinia demonstrated wide pharmacological activities, including sedative, antibacterial, antivirus, and antitumor activities and protection efficacies of the liver and gallbladder, among others.
The plant resources of genus Patrinia in China are very rich, and there are a large number of prescriptions in traditional Chinese medicine practice, mainly depending on Patrinia plants, such as Baijiang San, Hongteng Baijiang Zaoci Tang, etc. However, the pharmacological effects of the compounds isolated from Patrinia are less studied, and the mechanisms are also not clearly elucidated. In addition, the phytochemical and pharmacological research have not been coherently combined together and comprehensively analyzed. Therefore, in the future research of Patrinia, we should further systematically explore the mechanisms and bioactive ingredient basis of Patrinia, which is of great significance for its in-depth research and rational development of Patrinia.
Fundings
This work was supported by National Natural Science Foundation of China (31900292), Science and Technology Development Program of Henan Province (202102110149), and Science and Technology Project of Kaifeng (1908005).
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Chinese Academy of Science Flora of China Editorial Board Flora of China. Flora of China. Beijing: Science Press; 1986, pp. 6–23.
Wang ZY, Wu ZY. Phytochemical taxonomy of several families of angiosperm-(7) phytochemical taxonomy of Valerianaceae. J Int Pharm Res. 1984;1:19–23.
Jiangsu College of New Medicine Science. The Saurus of Chinese Traditional Medicine. Shanghai: Shanghai People’s Publishing House; 1977, pp. 2445–6.
Yang XP, Investigation on the chemical components and bioactivities of one medical plant of Valerianaceae. Lanzhou Univ; 2006.
Xia MW, Tan JJ, Yang L, Shang ZP, Zhao QC, Shi GB. Studies on chemical constituents in Patrinia scabiosaefolia. Chin Tradit Herb Drug. 2010;41:1612–5.
Bukharov VG, Karlin VV, Sidorovich TN. Triterpene glycosides of Patrinia scabiosofolia I. Khim Prir Soedin. 1970;6:69–74.
Woo WS, Choi JS, Seligmann O, Wagner H. Sterol and triterpenoid glycosides from the roots of Patrinia scabiosaefolia. Phytochemistry. 1983;22:1045–7. https://doi.org/10.1016/0031-9422(83)85060-2.
Yang B, Tong L, Jin M, Chen Y. Isolation and identification of triterpenoid compound from Patrinia scabiosaefolia. J Chin Med Mater. 1998;21:513–4. https://doi.org/10.13863/j.issn1001-4454.1998.10.011.
Yang DH, Wei LX, Cai SQ, Wang X. Studies on the chemical constituents of Patrinia scabiasaefolia Fisch. Chin J Chin Mater Med. 2000;25:39–41. https://doi.org/10.3321/j.issn:1001-5302.2000.01.014.
Yang B, Shen DF, Ding LX, Chen YJ. Isolation and identification of new acetylated saponin from radix and rhizome of Patrinia scabiosaefolia. Chin Tradit Herb Drug. 2002;33:15–7. https://doi.org/10.3321/j.issn:0253-2670.2002.08.006.
Choi JS, Woo WS. Coumarins and triterpenoid glycosides from the roots of Patrinia scabiosaefolia. Arch Pharm Res. 1984;7:121–6. https://doi.org/10.1007/BF02856624.
Choi JS, Woo WS. Triterpenoid glycosides from the roots of Patrinia scabiosaefolia. Planta Med. 1987;53:62–5. https://doi.org/10.1055/s-2006-962622.
Li YF, Lou FC. Isolation and identification of triterpenoid saponins from Patrinia scabiosaefolia Fisch. West Chin J Pharm Sci. 2007;22:483–6. https://doi.org/10.3969/j.issn.1006-0103.2007.05.002.
Kim YH. Studies on components of Patrinia scabiosaefolia. Korea J Pharmacgon. 1997;28:93–8.
Kang SS, Kim JS, Kim YH, Choi JS. A triterpenoid saponin from Patrinia scabiosaefolia. J Nat Prod. 1997;60:1060–2. https://doi.org/10.1021/np970175v.
Gao L, Zhang L, Li N, Liu JY, Cai PL, Yang SL. New triterpenoid saponins from Patrinia scabiosaefolia. Carbohydr Res. 2011;346:2881–5. https://doi.org/10.1080/10286020.2011.653685.
Bukharov VG, Karlin VV. Glycosides of Patrinia sibirica I. Khim Prir Soedin. 1970;6:56–9. https://doi.org/10.1007/BF00564158.
Nakanishi T, Tanaka K, Murata H, Somekawa M, Inada A. Phytochemical studies of seeds of medicinal plants. III. Ursolic acid and oleanolic acid glycosides from seeds of Patrinia scabiosaefolia Fisch. Chem Pharm Bull (Tokyo). 1993;41:183–6. https://doi.org/10.1248/cpb.41.183.
Bukharov VG, Talan VA, Karlin VV. Glycosides of Patrinia intermedia. Khim Prir Soedin. 1967;3:180. https://doi.org/10.1007/BF00568001.
Bukharov VG, Talan VA, Karlin VV. Triterpene glycosides of Patrinia intermedia. Khim Prir Soedin. 1969;5:17–9. https://doi.org/10.1007/BF00564912.
Bukharov VG, Talan VA, Karlin VV. The triterpene glycosides of Patrinia intermedia Roem et Schult. Khim Prir Soedin. 1969;5:76–8. https://doi.org/10.1007/BF00633279.
Bukharov VG, Karlin VV. Triterpenic glycosides of Patrinia scabiosaefolia II. Khim Prir Soedin. 1970;6:211–4. https://doi.org/10.1007/BF00941682.
Bukharov VG, Karlin VV. Structure of scabioside F. Khim Prir Soedin. 1970;6:372. https://doi.org/10.1007/BF00567336.
Yang B, Ding LX, Shen DF, Chen YJ, Pei YP. Isolation and identification of new saponin from Patrinia scabiosaefolia. J Chin Med Mater. 1999;22:189–90. https://doi.org/10.13863/j.issn1001-4454.1999.04.014.
Yang B, Fu ZZ, Zhang Y, Chen YJ. Isolation and identification of a new saponin from Dahurian Patrinia root and rhizome (Patrinia scabiosaefolia). Chin Tradit Herb Drug. 2000;31:1–2. https://doi.org/10.3321/j.issn:0253-2670.2000.01.001.
Li YF, Li MH, Lou FC, Tang YP. Studies on the constituents of Patrinia scabiosaefolia Fisch. J Chin Pharm Univ. 2002;33:101–3. https://doi.org/10.3321/j.issn:1000-5048.2002.02.005.
Inada A, Yamada M, Murata H, Kobayashi M, Toya H, Kato Y, et al. Phytochemical studies of seeds of medicinal plants. Two sulfated triterpenoid glycosides, sulfapatrinosides I and II from seeds of Patrinia scabiosaefolia. Chem Pharm Bull. 1988;36:4269. https://doi.org/10.1248/cpb.36.4269.
Gao L. Chemical constituents of Patrinia scabiosaefolia Fisch. Chin Tradit Herb Drug. 2011;42:1477–80. https://doi.org/10.7666/d.y1909827.
Yang B, Jin M, Tong LH, Chen YJ. Isolation and identification of oleanonic acid from Patrinia scabiosaefolia. J Chin Med Mater. 1999;22:23–4. https://doi.org/10.13863/j.issn1001-4454.1999.01.010.
Yang MY, Choi YH, Yeo H, Kim J. A new triterpene lactone from the roots of Patrinia scabiosaefolia. Arch Pharm Res. 2001;24:416–7. https://doi.org/10.1007/BF02975186.
Cao YP. Study on pharmacognosy of Patrinia scabiosaefolia. Liaoning Univ Trad Chin Med 2010. https://doi.org/10.7666/d.y1750856.
Gao L, Zhang L, Wang LM, Liu JY, Cai PL, Yang SL. New triterpenoid saponins from Patrinia scabiosifolia. J Asian Nat Prod Res. 2012;14:333–41. https://doi.org/10.1080/10286020.2011.653685.
Inada A, Murata H, Tanaka K, Somekawa M, Nakazawa T, Nishi M, et al. Phytochemical studies of seeds of medicinal plants IV. Flavonoids and triterpenoids from Patrinia villosa (Thunb.) Juss. Shoyakugaku Zasshi. 1993;47:301–4.
• Liu L. Study on anti-tumor active substance of Patrinia heterophylla Bung. Shanxi Univ Chin Med. 2017. This article reviewed nine compounds isolated from Patrinia heterophylla Bung.
Ding L, Xu FC, Wang H, Ou QM. Studies on chemical constituents from Patrinia heterophylla Bunge and their cytotoxicity in vitro. J Northwest Norm Univ. 2007;43:62–5. https://doi.org/10.3969/j.issn.1001-988X.2007.03.016.
•• Zheng CJ, Cui WY, Wang RL, Chao L, Quan S, Lu KY, et al. Chemical constituents of Patina scabiosaefolia. Chin Tradit Herb Drug. 2019;50:1890–7. https://doi.org/10.7501/j.issn.0253-2670.2019.08.017This article reviewed eighteen compounds isolated from the ethanol extract of Patina scabiosaefolia and included a new compound.
Taguchi H, Yokokawa Y, Endo T. Studies on the constituents of Patrinia villosa Juss. Yakuyaka ZasShi. 1973;93:607–11. https://doi.org/10.1248/yakushi1947.93.5_607.
Zu LB. The chemical constituents from Patrinia scabiosaefolia Fisch. Anhui Univ 2013.
Xu CJ, Zeng XY, Yu DQ. Study on the constituents from Patrinia villosa. Acta Pharmacol Sin. 1985;20:652–7. https://doi.org/10.16438/j.0513-4870.1985.09.003.
Kouno I, Yasuda I, Mizoshiri H, Tanaka T, Marubayashi N, Yang DM. Two new iridolactones and their glycosides from the roots of Patrinia scabra. Phytochemistry. 1994;37:467–72. https://doi.org/10.1016/0031-9422(94)85081-X.
Taguchi H. Patrinoside: a new iridoid glycoside from Patrinia scabiosaefolia. Chem Pharm Bull. 1974;22:1935–7.
Di L, Li N, Zu LB, Wang KJ, Zhao YX, Wang Z. Three new iridoid glucosides from the roots of Patrinia scabra. Bull Kor Chem Soc. 2011;32:3251–4. https://doi.org/10.5012/bkcs.2011.32.9.3251.
Di L Studies on the chemical constituents of Patriniascabra Bunge and their anti-tumor activity. Anhui Univ. 2012. https://doi.org/10.7666/d.y2114031.
Choi EJ, Liu QH, Jin QL, Shin JE, Hong JK, Lee DG, et al. New iridoid esters from the roots of Patrinia scabiosaefolia. Bull Kor Chem Soc. 2009;40:1407–9. https://doi.org/10.1002/chin.200945189.
Li N, Di L, Gao WC, Wang KJ, Zu LB. Cytotoxic iridoids from the roots of Patrinia scabra. J Nat Prod. 2012;75:1723–8. https://doi.org/10.1021/np300286t.
Yao ZY, Isolation and analysis of iridoids from Patrinia Scabra Bunge. Lanzhou Univ Technol 2012. https://doi.org/10.7666/d.Y2110228.
Liu FL, Feng F, Liu WY. Chemical constituents of Patrinia scabra. Pharm Clin Res. 2010;18:356–62. https://doi.org/10.3969/j.issn.1673-7806.2010.04.011.
Yang GJ, Gu ZB, Liu WY, Qiu Y, Li TZ, Zhang WD. Two new iridoids from Patrinia scabra. J Asian Nat Prod Res. 2004;6:277–80. https://doi.org/10.1080/10286020310001595953.
Gu ZB. Studies on immunocompetent constituents of Patrinia scabra Bunge. Acad J Second Mil Univ. 2001:11–6. https://doi.org/10.7666/d.y399733.
Yang XP, Li EW, Zhang Q, Yuan CS, Jia ZJ. Five new iridoids from Patrinia rupestris. Chem Biodivers. 2006;31:762–70. https://doi.org/10.1002/cbdv.200690078.
Yang XP, Yuan CS, Jia ZJ. Chemical constituents from the roots of Patrinia rupestris. J Chin Chem Soc. 2007;54:459–63. https://doi.org/10.1002/jccs.200700064.
Qiu DF, Yang XP, Xu YJ, Liu XQ, Liu HL, Yuan CS. A new iridoid compound from Patrinia rupestris (pall.) Juss. Nat Prod Res. 2011;25:1662–5. https://doi.org/10.1080/14786419.2010.533667.
Kouno I, Koyama I, Jiang ZH, Tanaka T, Yang DM. Patrinioside, an esterified monocyclic iridoid glucoside from Patrinia scabra. Phytochemistry. 1995;40:1567–8. https://doi.org/10.1016/0031-9422(96)00102-1.
Wan X, Shi JL, Liu Y, Xiao PG. The chemical constituents and pharmacological effects of Patrinia genus. World Phytomed. 2006;21:53–9. https://doi.org/10.7501/j.issn.1674-5515.2006.2.136.
• Jiang J. Studies on chemical constituents of ethyl acetate extraction phase from Patrinia scacbiosaefolia Fisch. Anhui Univ. 2017. This article reviewed fourteen compounds isolated from the Patina scabiosaefolia.
Lei HM, Zhu R, Lu JX, Li YL. The study of flavonoids in Patrinia heterophylla Bunge. Northwest Pharm J. 1995;10:154–6.
Gu ZB, Yang GJ, Cong HY, Xu YX, Chen HS, Zhang WD. Studies on chemical constituents from root of Patrinia scabra. Chin Tradit Herb Drug. 2002;33:781–2. https://doi.org/10.7501/j.issn.0253-2670.2002.9.402.
Peng JY, Fan GR, Wu YT. Studies on the chemical constituents of Patrinia villosa. Chin J Chin Mater Med. 2006;31:128–30.
Peng JY, Fan GR, Hong Z, Chai YF, Wu YT. Preparative separation of isovitexin and isoorientin from Patrinia villosa Juss by high-speed counter-current chromatography. J Chromatogr A. 2005;1074:111–5. https://doi.org/10.1016/j.chroma.2005.05.097.
Huang L, Zhang RS, Wang CF, Zhang SF. Studies on chemical constituents of Patrinia villosa. J Chin Med Mater. 2007;30:415–7.
Peng JY, Fan GR, Wu YT. Isolation and structure identification of chemical constituents from Patrinia villosa. Acta Pharmacol Sin. 2006;41:236–40. https://doi.org/10.1097/00024382-200610001-00089.
•• Xiang Z, Chen N, Xu Y, Wu J, Liu YJ, Tan C, et al. New flavonoid from Patrinia villosa. Pharm Biol. 2015;9:1–4. https://doi.org/10.3109/13880209.2015.1064449This article provided a new flavonoid named patriniaflavanone A isolated from Patrinia villosa.
Peng JY, Fan GR, Wu YT, Chen HY. Isolation and purification of prenylated flavonoids from Patrinia villosa Juss by reversed phase preparative liquid chromatography. Chin J Anal Chem. 2006;7:983–6. https://doi.org/10.1016/S1872-2040(06)60046-7.
Peng JY, Yang GJ, Fan GR, Wu YT. Preparative isolation and separation of a novel and two known flavonoids from Patrinia villosa Juss by high-speed counter-current chromatography. J Chromatogr A. 2005;1092:235–40. https://doi.org/10.1016/j.chroma.2005.07.073.
Peng JY, Fan GR, Wu YT. Preparative isolation of four new and two known flavonoids from the leaf of Patrinia villosa Juss. by counter-current chromatography and evaluation of their anticancer activities in vitro. J Chromatogr A. 2006;1115:103–11. https://doi.org/10.1016/j.chroma.2006.02.079.
Bukharov VG, Talan VA, Karlin VV. Nontriterpenoid glycosides of Patrinia intermedia. Khim Prir Soedin. 1968;4:213–6. https://doi.org/10.1007/BF00571130.
Li TZ, Zhang WD, Gu ZB, Liu WY, Zhou J, Chen WS. Studies on the lignans from Patrinia scabra. Acta Pharm Sin. 2003;38:520–2. https://doi.org/10.3321/j.issn:0513-4870.2003.07.011.
Li TZ, Zhang WD, Gu ZB, Liu WY, Zhang C, Liu RH. Lignans from Patrinia scabra. Chin Tradit Herb Drug. 2005;36:338–40. https://doi.org/10.3321/j.issn:0253-2670.2005.03.006.
Gu ZB, Chen XJ, Yang GJ, Li GJ, Liu WY, Zhang WD. Studies on immunocompetent constituents of Patrinia scabra Bunge. J Chin Med Mater. 2002;25:178–9. https://doi.org/10.3321/j.issn:1001-4454.2002.03.012.
• Bao YR, Yan XJ, Yang XX, Wang S, Zhao L, Bai M, et al. Studies on chemical constituents of Patrinia villosa Herbs. J Chin Med Mater. 2017;40:347–9. https://doi.org/10.13863/j.issn1001-4454.2017.02.021This article reviewed seven compounds isolated from Patrinia villosa.
Peng JY, Fan GR, Wu YT. Studies on chemical constituents of Patrinia villosa Juss. J Chin Med Mater. 2005;28:883–4. https://doi.org/10.13863/j.issn1001-4454.2005.10.011.
Yang B, Shen DF, Zhao P, Li LJ. Study on the chemical components from Patrinia scabiosaefolia Fish ex link by super critical fluid extraction. Lishizhen Med Mater Med Res. 2007;18:2706–7. https://doi.org/10.3969/j.issn.1008-0805.2007.11.054.
Tian ZY, Cao JH. Studies on chemical components of volatile oils of Patrinia scabiosaefolia Fisch and Patrinia heterphylla Bunge. J Henan Univ (Med Sci). 2004;23:35–9. https://doi.org/10.3969/j.issn.1672-7606.2004.01.014.
Ma YM, Tian Z, Lou ZC. Isolation and identification of volatile oil from Patrinia heterphylla. Trad Chin Med J. 1987;12:38–9.
He FJ, Li HG, Yang JP. Studies on the chemical components of Patrinia scabra. I. The chemical components of the volatile oil. Chin J Pharm Anal. 1991;11:67–70.
Lu WZ. Study on anti-cervical cancer mechanism of polysaccharides of Patrinia heterophylla Bunge. Northwest A&F Univ 2009.
Luo HC, Cui YH, Lou ZC. Study on clinical observation and pharmacological of sedative hypnotic effect of Patrinia scabiosaefolia Fisch. J Beijing Trad Chin Med. 1982;3:30–3.
Xiao Z, Xiang XD. Studies on the sedation active site of Patrinia scabiosaefolia Fisch. Guangzhou Med J. 2010;41:53–5. https://doi.org/10.3969/j.issn.1000-8535.2010.06.027.
Qi Z, Tian Z, Qin YX, Lou ZC. Sedative effect of the volatile oil from the rhizoma and roots Patrinia scabra Bunge. Nat Prod Res Dev. 1989;4:82–4.
Ma YM, Qi Z, Cui JR, Lou ZC. Sedative action of the volatile oil of Patrinia heterophylla. Mod J Integr Trad Chin Western Med. 1987;7:671–3. https://doi.org/10.7661/CJIM.1987.11.671.
Chen YP, Zeng J, Ye HY. Inhibitory effect of aqueous extract of Patrina villosa Juss on central nerve system. Chin Rem Clin. 2005;5:439–40. https://doi.org/10.3969/j.issn.1671-2560.2005.06.012.
Cai ZQ, Yang M. Inhibitory effect of several Patrinia preparation. J Chin Med Mater. 1989;12:38–40.
Tan C, Sun ZL, Zhou KY, Xu JP. Studies on chemical constituents and sedation and antibacterial effect of Patrinia scabiosaefolia Fisch. J Trad Chin Vet Med. 2003;4:3–5. https://doi.org/10.3969/j.issn.1000-6354.2003.04.001.
Shi YP, Fu YF. Clinical study on relationship between liver-blood stasis and liver fibrosis. Mod J Integr Tradi Chin Western Med. 1997;17:99–100. https://doi.org/10.7661/CJIM.1997.2.99.
Seo SW, Park CS, Hong SH, Kwon KB, Moon HC, Song BK, et al. Inhibitory effect of Patrinia scabiosaefolia on acute pancreatitis. World J Gastroenterol. 2006;12:1110–4. https://doi.org/10.1186/1471-230X-6-8.
Li N Studies on chemical constituents and anti-inflammation effect and extract and purifying technique of total saponins of white Patrinia. Chengdu Univ TCM 2006. https://doi.org/10.7666/d.y1007776.
Shi KK, Duan KH, Yang J. Therapeutic effects of Baijiang decoctions on chronic pelvic inflammation in rats. J Math Med. 2006;19:169–71. https://doi.org/10.3969/j.issn.1004-4337.2006.02.028.
Li SS, Li HY, Piao YA, Liu DL, Tian WJ, Dong YM. The anti-respiratory syncytial virus effect of an active compound (AP3) from a Chinese medicinal herb Patriniae in vitro. Chin J Epidemiol. 2004;25:150–3. https://doi.org/10.3760/j.issn:0254-6450.2004.02.016.
Zhang T, Li Q, Li K, Li Y, Li J, Wang G, et al. Antitumor effects of saponin extract from Patrinia villosa (Thunb.) Juss on mice bearing U14 cervical cancer. Phytother Res. 2008;22:640–5. https://doi.org/10.1002/ptr.2354.
Nakanishi T, Inada A, Tanaka K. Antiviral cyclic triterpenoids from Patrinia. Jpn Patent 01207262, 1989.
Lee JH, Van ND, Ma JY. Screening of antiviral medicinal plants against avian influenza virus H1N1 for food safety. Korean J Food Sci Anim Resour. 2010;30:345–50. https://doi.org/10.5851/kosfa.2010.30.2.345.
Yang B, Li N, Wang YQ, Chen J, Zhang RS. Preliminary evaluation of antitumor effect and induction apoptosis in PC-3 cells of extract from Patrinia heterophylla. Rev Bras Farm. 2011;21:471–6. https://doi.org/10.1590/S0102-695X2011005000100.
Xu FC. Studies on the chemical constituents of Patrinia heterophylla Bunge and their anti-tumor activities J Northwest Norm Univ 2007. https://doi.org/10.7666/d.y1132038.
Chen JX, Wang D, Wang J, Yu HB. Effects of Yiye Baijiang Zonggan tablets on apoptosis of human colon cancer HT-29 cells. Chin Hosp Pharm J. 2007;27:159–61. https://doi.org/10.3321/j.issn:1001-5213.2007.02.007.
Mao JQ, Li TJ, Qiu Y, Rui YC, Gu ZB. Effects of the iridoid aglycones from Patrinia scabra on colon cancer. J Pharm Pract. 2007;25:10–2. https://doi.org/10.3969/j.issn.1006-0111.2007.01.004.
Li TJ, Qiu Y, Rui YC, Gu ZB. Anti-tumor effects of the iridoid aglycones from Patrinia scabra in vitro. Pharm J Chin PLA. 2004;20:101–2. https://doi.org/10.3969/j.issn.1008-9926.2004.02.008.
Chen R, Zhao JX, Wang XX, Li SG, Wang HJ. Growth-inhibiting effect of Patrinia scabra Bunge lignanoid on K562 cells. J Sichun Trad Chin Med. 2007;25:14–7. https://doi.org/10.3969/j.issn.10003649.2007.05.008.
Chen R, Zhao JX, Wang XX. Comparing the differences among Patrinia scabra Bunge extractions of growth-inhibiting effects of on tumor cell in vitro. J Sichun Trad Chin Med. 2011;29:50–2.
Chu ZY, Li TJ, Qiu Y, Gu ZB, Shen XR, Jiang DW. Effect of iridoid aglycones from Patrinia scabra on immune function of mice. J Chin Med Mater. 2008;31:882–8. https://doi.org/10.3321/j.issn:1001-4454.2008.06.029.
Chen L, Zhang T, Tian LM, Chen P, Wang DW, Lu CF, et al. Inhibitory effect of Patrinia villosa extract on U (14) cervical cancer cells in mice. Chin J Gerontol. 2010;30:1091–3. https://doi.org/10.3969/j.issn.1005-9202.2010.08.030.
Mao JJ, Wang LM, Zhang MY, Liu L, Lu YZ, Fu ZZ, et al. Experimental observation on antitumor effect of Patrinia scabra extract. Heilongjiang Med Pharm. 2004;27:35. https://doi.org/10.3969/j.issn.1008-0104.2004.05.014.
Shen DF, Yam B, Li JJ. Experimental research on the function of anti-cancer in the saponins from Patrinia scabiosaefolia Fisch. Heilongjiang Med Pharm. 2007;30:35. https://doi.org/10.3969/j.issn.1008-0104.2007.03.014.
Liu LY, Shen A, Chen YQ, Wei LH, Lin JM, Sferra TJ, et al. Patrinia scabiosaefolia induces mitochondrial-dependent apoptosis in a mouse model of colorectal cancer. Oncol Rep. 2013;30:897–903. https://doi.org/10.3892/or.2013.2528.
Peng J, Chen Y, Lin J, Zhuang Q, Xu W, Hong Z, et al. Patrinia scabiosaefolia extract suppresses proliferation and promotes apoptosis by inhibiting the STAT3 pathway in human multiple myeloma cells. Mol Med Rep. 2011;4:313–8. https://doi.org/10.3892/mmr.2011.413.
• Zhang MY, Sun GD, Shen AL, Liu LY, Ding JZ, Peng J. Patrinia scabiosaefolia inhibits the proliferation of colorectal cancer in vitro and in vivo via G1/S cell cycle arrest. Oncol Rep. 2015;33:856–60. https://doi.org/10.3892/or.2014.3663The article is one axample indicating that ethanol extract of Patrinia scabiosaefolia inhibit CRC growth both in in vitro and in vivo.
Li YF, Lou FC, Tang YP, Wang JH. Advances of researches in Patrinia Juss. Nat Prod Res Dev. 2001;13:71–4. https://doi.org/10.3969/j.issn.1001-6880.2001.03.020.
Jiang HD, Huang XQ, Yang Y, Zhang QL. Studies on the antilipid peroxidation of nine sorts of Chinese herbal medicines with the function of protecting liver. J Chin Med Mater. 1997;20:624–6. https://doi.org/10.13863/j.issn1001-4454.1997.12.015.
Ma XH, Zhao YC, Yin L, Han DW. Studies on the effect of oleanolic acid on experimental liver injury. Acta Pharm Sin. 1982;17:93–7. https://doi.org/10.1016/j.apsb.2015.02.001.
Fu GH, Xu F, Lu HZ. Effect of six Chinese herbs on IL-6 secretion by macrophages stimulated by endotoxin. Chin Tradit Herb Drug. 1997;28:166–9. https://doi.org/10.7501/j.issn.0253-2670.1997.3.084.
Li PF. Influence of herba Patrinia on endotoxin-stimulated secretory cell factor of macrophage and its mechanism. J New Chin Med. 2001;33:75–6. https://doi.org/10.3969/j.issn.0256-7415.2001.02.051.
Wang YT, Pan XB, Liu X, Yan YX. Preliminary observation on the effects of Patrinia Scarbra Bunge, Tremella Aurantia and fructus Ligustri Lucidi-Radix Astragali Fu-Zheng Powder on the immune function in mice. J Lanzhou Univ Med Sci. 1989;15:59–65. https://doi.org/10.13885/j.issn.1000-2812.1989.02.001.
Wang XX, Zhao JX, Cheng WD, Chen R, Bai DC. Erythrocyte immunologic function effects of Patrinia scabra extracts by macroporous adsorptive resins on mice burdened transplanted tumor. J Chin Med Mater. 2007;30:1414–7. https://doi.org/10.3321/j.issn:1003-5370.2007.08.018.
Wang XX, Lu L, Wang M, Wang Y, Qian WN, Li SH. Immune regulatory effect of Patrinia scabra Bunge extract separated by macroporous adsorptive resins on Sarcoma180 transplanted mice. Pharm Clin Chin Mater Med. 2012;28:71–4. https://doi.org/10.13412/j.cnki.zyyl.2012.03.047.
Sun WL, Yao XJ, Mao XM, Ma LF, Wei HL, Zhao HS, et al. Experimental studies on MTT detection of the cytotoxic effect on leukemia cells by Patrinia scabra. J Gansu Coll Trad Chin Med. 1990;7:34–6.
Ding L, Hou Q, Xu FC, Zhang Q, Wang H, Liu GA. The effect of Hederagenin, a triterpenoid from Patrinia heterophylla Bunge on the proliferation inhibition, cell cycle arrest and apoptosis of human promyelocytic leukemia HL-60 cells. J Northwest Norm Univ. 2009;45:88–93. https://doi.org/10.3969/j.issn.1001-988X.2009.01.020.
Zhang YX, Wang HF, Huang ZS, Ying GH, Ding XY, Wu JM, et al. Experimental study on mice treated with tumors by Patrinia scabra. J Integr Trad Chin Western Med. 1984;4:109–11. https://doi.org/10.7661/CJIM.1984.2.109.
Dang YL, Zhang YL, Li SY. An experimental study on mechanism of hemostatic action of Patrinia Scabra Bge. J Lanzhou Univ Med Sci. 1990;16:197–200. https://doi.org/10.13885/j.issn.1000-2812.1990.04.007.
Jiang QY, Zhong L, Fang G, Su LM. Effect of Mutouhui extracts on hemorheology of U14 cervical cancer mice. Chin J Inf Trad Chin Med. 2008;15:25–6. https://doi.org/10.3969/j.issn.1005-5304.2008.10.010.
Zhao L, Li XY, Ma HZ. Experimental studies on the formation of cord blood stromal cell and secretion of GM-CSF induced by Patrinia scabra. Chin Tradit Herb Drug. 2001;32:58–60. https://doi.org/10.7501/j.issn.0253-2670.2001.1.029.
Zhang JY. Treatment of chronic ulcerative colitis by Patrinia. J Tradit Chin Med. 2002;43:892. https://doi.org/10.3321/j.issn:1001-1668.2002.12.003.
Zhu JJ, Wu XY, Zou SJ, Wu J. Extraction technology and anti-constipation function of tannins from wild Patrinia villosa. Trans CSAE. 2003;19:186–9. https://doi.org/10.3321/j.issn:1002-6819.2003.02.044.
Meng LY, Lu JK, Cai WQ, Qu HY, Liu JF, Lan TF, et al. Antioxidant activities in vivo of the extract from Patrinia. Sci Technol Food Ind. 2012;33:372–4.
Wan GL, Li HL, Yang QC, Zeng J. Effect of Patrina villosa Juss extract on hypoxia tolerance. Lishizhen Med Mater Med Res. 2008;19:1130–1. https://doi.org/10.3969/j.issn.1008-0805.2008.05.054.
Zhu T. Treatment of oviduct obstruction by Patrinia villosa. J Tradit Chin Med. 2002;43:893. https://doi.org/10.3321/j.issn:1001-1668.2002.12.007.
Sun FL. Reusing Patrinia in the treatment of non-liquefaction of semen. J Tradit Chin Med. 2002;43:894. https://doi.org/10.13288/j.11-2166/r.2002.12.010.
Tohda C, Kakihara Y, Komatsu K, Kuraishi Y. Inhibitory effects of methanol extracts of herbal medicines on substance P-induced itch-scratch response. Biol Pharm Bull. 2000;23:599–601. https://doi.org/10.1248/bpb.23.599.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of Interest
All the authors declare that there are no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Natural Products: From Chemistry to Pharmacology
Rights and permissions
About this article
Cite this article
Meng, L., Chen, S., Zhou, L. et al. Chemical Constituents and Pharmacological Effects of Genus Patrinia: a Review. Curr Pharmacol Rep 6, 380–414 (2020). https://doi.org/10.1007/s40495-020-00240-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40495-020-00240-7